Lifestyle Drugs Global Market by Therapy area, Trends, Analysis and Outlook to 2021
ReportsWeb.com published “Lifestyle Drugs Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, April 25, 2018 ) About Lifestyle Drugs Market
Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.
Publisher's analysts forecast the global Lifestyle Drugs Market to grow at a CAGR of 2.87% during the period 2017-2021.
For more information http://www.reportsweb.com/global-lifestyle-drugs-market-2017-2021
Covered in this report
The report covers the present scenario and the growth prospects of the global lifestyle drugs market for 2017-2021. To calculate the market size, the report considers sales of lifestyle drugs in the market.
The market is divided into the following segments based on geography:
- Americas
- EMEA
- APAC
Publisher's report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Allergan
- BMS
- Eli Lilly
- Pfizer
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001685348/sample
Other prominent vendors
- Acerus Pharmaceuticals
- Alkermes
- Amorepacific
- AndroScience
- Anterios
- AstraZeneca
- Avanir Pharmaceuticals
- Avolynt
- Celtaxsys
- Cerecor
- Corcept Therapeutics
- Cosmo Pharmaceuticals
- CTC Bio
- Dermira
- Dong-A ST
- Euthymics Bioscience
- Foamix
- Follicum
- Forendo Pharma
- Futura Medical Developments
- Galderma
- Hanmi Pharmaceutical
- Incyte
- Intrepid Therapeutics
- Ion Channel Innovations
- iX Biopharma
- Johnson & Johnson
- Legacy Healthcare
- LEO Pharma
- H. Lundbeck
- Luye America Pharmaceuticals
- Merck
- Minerva Neurosciences
- MSI Methylation Sciences
- Neuralstem
- Novan
- Novartis
- Novo-Nordisk
- Palatin Technologies
- Paratek Pharmaceuticals
- Photocure
- Revance Therapeutics
- Rhythm Pharmaceuticals
- S1 Biopharma
- Sage Therapeutics
- Samumed
- Sanofi
- Sigma-Tau Pharmaceuticals
- Strategic Science & Technologies
- Sumitomo Dainippon Pharma
- Takeda
- TetraLogic Pharmaceuticals
- TherapeuticsMD
- Valeant Pharmaceuticals
- VistaGen Therapeutics
- VIVUS
- XBiotech
- Yuhan
- Zafgen
Market driver
- Lifestyle changes
- For a full, detailed list, view our report
Market challenge
- Patent expiries
- For a full, detailed list, view our report
Market trend
- Increase in M&A
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/buy&RW0001685348/buy/3500
Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.
Publisher's analysts forecast the global Lifestyle Drugs Market to grow at a CAGR of 2.87% during the period 2017-2021.
For more information http://www.reportsweb.com/global-lifestyle-drugs-market-2017-2021
Covered in this report
The report covers the present scenario and the growth prospects of the global lifestyle drugs market for 2017-2021. To calculate the market size, the report considers sales of lifestyle drugs in the market.
The market is divided into the following segments based on geography:
- Americas
- EMEA
- APAC
Publisher's report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Allergan
- BMS
- Eli Lilly
- Pfizer
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001685348/sample
Other prominent vendors
- Acerus Pharmaceuticals
- Alkermes
- Amorepacific
- AndroScience
- Anterios
- AstraZeneca
- Avanir Pharmaceuticals
- Avolynt
- Celtaxsys
- Cerecor
- Corcept Therapeutics
- Cosmo Pharmaceuticals
- CTC Bio
- Dermira
- Dong-A ST
- Euthymics Bioscience
- Foamix
- Follicum
- Forendo Pharma
- Futura Medical Developments
- Galderma
- Hanmi Pharmaceutical
- Incyte
- Intrepid Therapeutics
- Ion Channel Innovations
- iX Biopharma
- Johnson & Johnson
- Legacy Healthcare
- LEO Pharma
- H. Lundbeck
- Luye America Pharmaceuticals
- Merck
- Minerva Neurosciences
- MSI Methylation Sciences
- Neuralstem
- Novan
- Novartis
- Novo-Nordisk
- Palatin Technologies
- Paratek Pharmaceuticals
- Photocure
- Revance Therapeutics
- Rhythm Pharmaceuticals
- S1 Biopharma
- Sage Therapeutics
- Samumed
- Sanofi
- Sigma-Tau Pharmaceuticals
- Strategic Science & Technologies
- Sumitomo Dainippon Pharma
- Takeda
- TetraLogic Pharmaceuticals
- TherapeuticsMD
- Valeant Pharmaceuticals
- VistaGen Therapeutics
- VIVUS
- XBiotech
- Yuhan
- Zafgen
Market driver
- Lifestyle changes
- For a full, detailed list, view our report
Market challenge
- Patent expiries
- For a full, detailed list, view our report
Market trend
- Increase in M&A
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/buy&RW0001685348/buy/3500
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results